Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/15542805

J. Clin. Oncol. 2004 Nov 15 22 22 4541-50

Download in:

View as

General Info

PMID
15542805